AstraZeneca's Farxiga meets main goal of heart failure study

British drugmaker AstraZeneca Plc said on Tuesday that its diabetes drug Farxiga met the main goal of a late-stage study for the treatment of patients with heart failure.

from Reuters: Health News https://ift.tt/30jBFJB
via IFTTT